The Covax vaccine initiative — a pooled arrangement to procure vaccines for a number of countries from a range of manufacturers — says that it does not expect delivery timelines to be disrupted despite a decision by the Indian government over the weekend to temporarily ban the export of the Indian-manufactured AstraZeneca Covid-19 vaccine.

The Covax initiative is the only firm commitment that SA has to gain access to a vaccine as the government has not secured orders directly with manufacturers. The Serum Institute of India, which will manufacture the Oxford University-AstraZeneca vaccine, among others, has a major role to play in Covax with an existing agreement to supply 200-million doses...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now